Acadia Healthcare (ACHC)

• Market cap: $2.37B
• 1 day: -4.53%
• 5 days: 5.89%
• 1 month: -2.54%
• 3 months: -37.36%
• 6 months: -34.65%
• Year to date: -36.91%
• 1 year: -63.94%
• 5 years: 5.11%
• 10 years: -62.44%
• Sector: Healthcare
• Industry: Medical Care Facilities

About: Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.

Employees: 25,500

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

680% more call options, than puts

Call options by funds: $92.7M | Put options by funds: $11.9M

75% more funds holding in top 10

Funds holding in top 10: 4 [Q3] → 7 (+3) [Q4]

28% more repeat investments, than reductions

Existing positions increased: 113 | Existing positions reduced: 88

2.22% more ownership

Funds ownership: 105.8% [Q3] → 108.02% (+2.22%) [Q4]

1% less first-time investments, than exits

New positions opened: 75 | Existing positions closed: 76

2% less funds holding

Funds holding: 306 [Q3] → 301 (-5) [Q4]

36% less capital invested

Capital invested by funds: $6.22B [Q3] → $3.98B (-$2.25B) [Q4]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $28 9% upside
• Avg. target: $40 55% upside
• High target: $55 114% upside

6 analyst ratings

• positive: 4 67%
• neutral: 2 33%
• negative: 0 0%

Mizuho Ann Hynes 47% 1-year accuracy 9 / 19 met price target	24% upside $32	Neutral Maintained	14 May 2025
Barclays Andrew Mok 49% 1-year accuracy 30 / 61 met price target	9% upside $28	Equal-Weight Maintained	14 May 2025
Keybanc Matthew Gillmor 35% 1-year accuracy 6 / 17 met price target	114% upside $55	Overweight Maintained	14 May 2025
Guggenheim Jason Cassorla 40% 1-year accuracy 6 / 15 met price target	40% upside $36	Buy Initiated	9 Apr 2025
RBC Capital Ben Hendrix 42% 1-year accuracy 30 / 72 met price target	67% upside $43	Outperform Maintained	3 Mar 2025